Literature DB >> 24916434

Implementing the ESHRE 'poor responder' criteria in research studies: methodological implications.

Athanasios Papathanasiou1.   

Abstract

The Bologna criteria for defining poor ovarian response (POR) during IVF provide a useful template for new research in this field of assisted conception. However, designing studies around the European Society for Human Reproduction and Embryology POR criteria can be methodologically challenging, as the new definition includes various POR subpopulations with diverse baseline characteristics and unknown clinical prognosis. When designing RCTs, potential result bias may be introduced if women from each subpopulation are not evenly allocated between intervention groups. In the case of small or moderate-size RCTs, a single-sequence randomization method may not ensure balanced allocation between groups. Stratified randomization methods provide an alternative methodological approach. Depending on the chosen methodology, patient characteristics and outcomes within each intervention group may be better reported according to relevant subpopulations.
© The Author 2014. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  IVF; RCT; criteria; poor ovarian response; poor responder

Mesh:

Year:  2014        PMID: 24916434     DOI: 10.1093/humrep/deu135

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  20 in total

1.  Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.

Authors:  Kate Devine; Sunni L Mumford; Mae Wu; Alan H DeCherney; Micah J Hill; Anthony Propst
Journal:  Fertil Steril       Date:  2015-06-11       Impact factor: 7.329

2.  Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study.

Authors:  Antonio La Marca; Valentina Grisendi; Simone Giulini; Giovanna Sighinolfi; Alessandra Tirelli; Cindy Argento; Claudia Re; Daniela Tagliasacchi; Tiziana Marsella; Sesh Kamal Sunkara
Journal:  J Assist Reprod Genet       Date:  2015-05-01       Impact factor: 3.412

Review 3.  Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR.

Authors:  Lisa M Pastore; Mindy S Christianson; James Stelling; William G Kearns; James H Segars
Journal:  J Assist Reprod Genet       Date:  2017-10-02       Impact factor: 3.412

4.  Efficacy and Safety of Pergoveris in Assisted Reproductive Technology--ESPART: rationale and design of a randomised controlled trial in poor ovarian responders undergoing IVF/ICSI treatment.

Authors:  P Humaidan; J Schertz; R Fischer
Journal:  BMJ Open       Date:  2015-07-03       Impact factor: 2.692

5.  An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis.

Authors:  Kuan-Chin Wang; Wen-Hsun Chang; Wen-Ling Lee; Nicole Huang; Hsin-Yi Huang; Ming-Shyen Yen; Chao-Yu Guo; Peng-Hui Wang
Journal:  BMC Cancer       Date:  2014-11-18       Impact factor: 4.430

Review 6.  The Bologna criteria for poor ovarian response: a contemporary critical appraisal.

Authors:  Johnny S Younis; Moshe Ben-Ami; Izhar Ben-Shlomo
Journal:  J Ovarian Res       Date:  2015-11-17       Impact factor: 4.234

Review 7.  Individualized controlled ovarian stimulation in expected poor-responders: an update.

Authors:  Thor Haahr; Sandro C Esteves; Peter Humaidan
Journal:  Reprod Biol Endocrinol       Date:  2018-03-09       Impact factor: 5.211

8.  Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.

Authors:  P Humaidan; W Chin; D Rogoff; T D'Hooghe; S Longobardi; J Hubbard; J Schertz
Journal:  Hum Reprod       Date:  2017-03-01       Impact factor: 6.918

Review 9.  Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why.

Authors:  Sandro C Esteves; Matheus Roque; Giuliano M Bedoschi; Alessandro Conforti; Peter Humaidan; Carlo Alviggi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-17       Impact factor: 5.555

10.  The Role of Traditional Chinese Formula Ding-Kun Pill (DKP) in Expected Poor Ovarian Response Women (POSEIDON Group 4) Undergoing In Vitro Fertilization-Embryo Transfer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Jing-Yan Song; Dan-Dan Gao; Xian-Ling Cao; Shan Xiang; Yan-Hua Chen; Yi-Li Teng; Xiu-Fang Li; Hai-Ping Liu; Fu-Xin Wang; Bin Zhang; Li-Hua Xu; Li Zhou; Xiang-Hong Huang; Zhen-Gao Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.